ARCHIVES

Opioid Pain Reliever Approved With Risk Reduction Plan

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977